The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension | Zendy

Н. Ш. Загидуллин | Zendy; Ш. З. Загидуллин | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension

Author(s) -

Н. Ш. Загидуллин,

Ш. З. Загидуллин

Publication year - 2009

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg33069

Subject(s) - losartan , hydrochlorothiazide , medicine , cardiology , combination therapy , angiotensin receptor , blockade , renin–angiotensin system , blood pressure , receptor

Blockade of renin-angiotensin systems is one problem in the treatment of arterial hypertension. Resistant hypertension and patients with high cardiovascularrisk demand frequently use of combination therapy. The efficiency of combined therapy losartan plus hydrochlorothiazide at patientswith arterial hypertension was studied in several large clinical multicentre randomized studies. It is proved high efficiency and safety of this combinationtherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research